Search Peptipedia.

Ask a question or explore a peptide. Read a plain-language explanation, then follow its sources for more detail.

Explore the research.

18 source papers

Original source papers

2025 DecCureus
Pyoderma Gangrenosum Secondary to Melanotan.
Dickson D, Hlaing Htwe S
PubMed · PMID 41487785Case Reports
2024 Apr 2Chemistry (Weinheim an der Bergstrasse, Germany)
5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.
Todorovic M, Blanc A, Wang Z et al.
PubMed · PMID 38285527Journal article
2023 SepBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Melanotan-II reverses memory impairment induced by a short-term HF diet.
Wekwejt P, Wojda U, Kiryk A
PubMed · PMID 37478579Journal article
2022 Mar 10Journal of medicinal chemistry
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.
Tomassi S, Dimmito MP, Cai M et al.
PubMed · PMID 35188390Journal article
2021Dermatology (Basel, Switzerland)
Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.
Gilhooley E, Daly S, McKenna D
PubMed · PMID 34464955Journal article
2020 MayCEN case reports
Melanotan II: a possible cause of renal infarction: review of the literature and case report.
Peters B, Hadimeri H, Wahlberg R et al.
PubMed · PMID 31953620Case Reports · Review
2019 Feb 21BMJ case reports
Melanotan-induced priapism: a hard-earned tan.
Dreyer BA, Amer T, Fraser M
PubMed · PMID 30796078Case Reports · Review
2018 May 15Dermatology online journal
A glimpse into the underground market of melanotan.
Callaghan Iii DJ
PubMed · PMID 30142729Observational Study
2014 Nov 26Journal of medicinal chemistry
1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activity.
Testa C, Scrima M, Grimaldi M et al.
PubMed · PMID 25347033Journal article
2013 JanJournal of the European Academy of Dermatology and Venereology : JEADV
Melanotan-associated transverse melanonychia.
Paurobally D, El Hayderi L, Richert B et al.
PubMed · PMID 22182016Case Reports · Letter
2012 MayActas dermo-sifiliograficas
[Melanotan].
Mahiques-Santos L
PubMed · PMID 22051769Journal article
2009 Feb 17BMJ (Clinical research ed.)
Use of melanotan I and II in the general population.
Evans-Brown M, Dawson RT, Chandler M et al.
PubMed · PMID 19224885Editorial
2007 SepThe Journal of pharmacology and experimental therapeutics
The effects of the melanocortin agonist (MT-II) on subcutaneous and visceral adipose tissue in rodents.
Strader AD, Shi H, Ogawa R et al.
PubMed · PMID 17567964Journal article
2005 SepEndocrinology
The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity.
Seeley RJ, Burklow ML, Wilmer KA et al.
PubMed · PMID 15932932Journal article
2003 JunAnnals of the New York Academy of Sciences
MT-II induces penile erection via brain and spinal mechanisms.
Wessells H, Hruby VJ, Hackett J et al.
PubMed · PMID 12851302Journal article
2003 Jul 11Brain research
Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats.
Trivedi P, Jiang M, Tamvakopoulos CC et al.
PubMed · PMID 12834882Comparative Study
2001 DecBritish journal of pharmacology
Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO.
Vemulapalli R, Kurowski S, Salisbury B et al.
PubMed · PMID 11739247Journal article
1999Peptides
Structure-function studies on the cyclic peptide MT-II, lactam derivative of alpha-melanotropin.
Bednarek MA, Silva MV, Arison B et al.
PubMed · PMID 10447101Journal article